FDA guidelines would expand access to unapproved drugs

12/11/2006 | NYTimes.com

The FDA proposed new guidelines for releasing unapproved drugs for patients who have no other options for treating life-threatening conditions. The proposed guidelines say drugs could be available during all stages of development, including initial, Phase I testing.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX